Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Current Applications and Future Challenges of Mesenchymal Stem Cell-Extracellular Vesicles in Tissue Engineering: A Bibliometric Analysis

Chen S., Di J., Zhang Z., Guo Z., Tian Z., Qin Y.

Narrative Review on Hip, published in Int J Nanomedicine (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Int J Nanomedicine (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41409041
PMCID
PMC12706372
DOI
10.2147/ijn.s549684
Citations
2

Abstract (original English)

Background Extracellular vesicles derived from mesenchymal stem cells (MSCs-EVs) are nano-sized vesicles and have become key mediators in tissue engineering and emerging therapeutic agents in regenerative medicine. This study systematically assessed the global research trend of MSCs-EVs for tissue engineering through bibliometric analysis of literature from 2014 to 2024. Methods A comprehensive search of Web of Science retrieved 752 eligible articles. We visualized and further analyzed collaboration, co-citation, co-authorship and co-occurrence through VOSviewer and Citespace, focusing on their application and future development trends. Results Annual publications increased continuously, with China and the United States accounting for 48.9% and 19.1% of research output, respectively, accompanied by intensive transnational cooperation. China leads in number of publications, number of years, total citations, H index and collaboration. The evolution of research trends confirms that the current field of application has expanded from cellular repair to drug delivery systems and biomaterial integration. Keyword cooccurrence reveals three clusters of research: artificial editing of exosomes (membranes), drug delivery (drugs, nucleic acids), and regeneration mechanisms (bone morphogenesis, angiogenesis regulation). The International Journal of Molecular Science became the most influent

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Mesenchymal Stem CellsAnimalsHumansDrug Delivery SystemsTissue EngineeringRegenerative MedicineBibliometricsChinaExtracellular Vesicles

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research